+467.0%
MRNA vs TCOM
-46.9%
+513.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | TCOM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.8% | +4.6% | +4.8% |
| 7D | -1.1% | -4.9% | +3.8% | +2.5% |
| 30D | +126.1% | -14.4% | +140.5% | +152.1% |
| 3M | +190.0% | -17.7% | +207.7% | +225.6% |
| 6M | +157.2% | -25.1% | +182.3% | +191.4% |
| YTD | +388.2% | -45.7% | +433.9% | +436.7% |
| 1Y | +467.0% | -47.9% | +514.9% | +556.0% |
| All | +467.0% | -46.9% | +513.9% | +556.0% |
Cumulative growth
Daily Returns
Daily percentage return beside TCOM.
Daily Out/Under-Performance
Portfolio return minus TCOM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TCOM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded TCOM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling